✦ LIBER ✦

A Model of Disease and Vaccination for Infections with Acute and Chronic Phases

✍ Scribed by Brian Reade; Roger G. Bowers; Michael Begon; Rosalind Gaskell

Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 502 KB
Volume: 190
Category: Article
ISSN: 0022-5193
DOI: 10.1006/jtbi.1997.0557

No coin nor oath required. For personal study only.

✦ Synopsis

A general model is presented of a disease in which both recovered and vaccinated individuals are protected from acute disease, but are still susceptible to chronic infection. The special threshold conditions for the establishment and persistence of such a disease are derived and explained in full. The efficacies of alternative vaccination strategies are detailed and a specific example of such a disease is given by examining feline calicivirus (FCV), a cause of upper respiratory tract disease in cats.

📜 SIMILAR VOLUMES

Mouse model for evaluation of antibiotic

Mouse model for evaluation of antibiotic treatment of acute and chronic infections

✍ J. Renneberg; M. Walder 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 577 KB

A Cellular Automata Model for Helper T C

A Cellular Automata Model for Helper T Cell Subset Polarization in Chronic and Acute Infection

✍ Andy Brass; Richard K. Grencis; Kathryn J. Else 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 474 KB

A cellular automata (CA) model has been built to study the interaction between T-helper subset cells in a secondary lymphoid organ during chronic and acute infection. The \(\mathrm{T}_{\mathrm{H}}\) subset cells interacted via short range cytokine-like factors, each cell type producing an autocrine

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

Meeting vaccination quality measures for

Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection

✍ Jennifer R. Kramer; Christine Y. Hachem; Fasiha Kanwal; Minghua Mei; Hashem B. E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 1 views

Coinfection with hepatitis A virus (HAV) or hepatitis B virus (HBV) in patients with chronic hepatitis C virus (HCV) is associated with increased morbidity and mortality. The Center for Medicare and Medicaid Services has identified HAV and HBV vaccination as a priority area for quality measurement i

Hematology of vaccinated and non-vaccina

Hematology of vaccinated and non-vaccinated long-billed corellas following infection with beak and feather disease virus (BFDV)

✍ Nicolai Bonne; Phillip Clark; Patrick Shearer; Margaret Sharp; Shane Raidal 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 199 KB